|
Kwon M, Gomez-Centurion I, Oarbeascoa G, Torres M, Martinez AP, Suarez-Lledo M, Chinea A, Cascon MJP, Vazquez L, Espigado I, Izquierdo I, Parody R, Cadenas IG, Calbacho M, Sierra PG, Heras I, Yanez L, Torrent A, Bautista G, Gonzalez S, Roldan E, Vallejo JC, Bailen R, Borrero A, Lopez-Jimenez J, Casas MAC, Solano C; Spanish Group of Hematopoietic Stem Cell Transplantation and Cell Therapy (GETH-TC). Real-World Experience with Isavuconazole in Allogeneic Stem Cell Transplantation in Spain. Transplant Cell Ther. 2024 Oct;30(10):1033.e1-1033.e8. doi: 10.1016/j.jtct.2024.06.009. Epub 2024 Jun 12. PubMed PMID: 38871055.
AÑO: 2024; IF: 4.4
|
38871055
|
Mora E, Montoro J, Balaguer A, Rovira M, Cabrero M, Heras I, Ribera JM, Antelo G, Martin AA, Lopez Godino O, Torrent A, Villalba M, Chorao P, Sanz MA, Sanz J; Grupo Espanol de Trasplante Hematopoyetico (GETH). Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia. Bone Marrow Transplant. 2024 Aug;59(8):1137-1145. doi: 10.1038/s41409-024-02298-z. Epub 2024 May 16. PubMed PMID: 38755458.
AÑO: 2024; IF: 5.2
|
|
Chorao P, Avendano A, Heras I, Aiello F, Mico-Cerda M, Arrufat Bel A, Garcia-Gutierrez V, Olave MT, Gomez MA, Espigado I, Cuesta-Casas MA, Gonzalez-Santillana C, Hernandez-Rivas JA, Roldan-Perez A, Labrador J, Villalba M, Vazquez L, Garcia Vidal C, Martino R, Lopez-Jimenez J, Cedillo A, Solano C, Garcia-Cadenas I, Pinana JL; Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation Cell Therapy Group (GETH-TC). Co-infections during SARS-CoV-2 infection in hematologic patients and cell therapy recipients in the omicron era: a Spanish hematopoietic stem cell transplantation and cell therapy group study. BMC Infect Dis. 2025 Jul 25;25(1):944. doi: 10.1186/s12879-025-11302-w. PubMed PMID: 40713537; PubMed Central PMCID: PMC12291501.
AÑO: 2025; IF: 3.0
|
|
Gimenez E, Cadenas IG, Pinana JL, Albert E, Vazquez L, Avendano A, Cabrero M, Esquirol A, Martino R, Lopez-Jimenez J, Cuesta MA, Humala K, Villar S, Rovira M, Heras I, Zudaire T, Arroyo I, Zabalza A, Aguado B, Solano C, Navarro D; Spanish Group for Hematopoietic Transplantation (GETH). Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study. Transpl Infect Dis. 2025 Jul 17:e70080. doi: 10.1111/tid.70080. Online ahead of print. PubMed PMID: 40674366.
AÑO: 2025; IF: 2.6
|